PMID- 37887262 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231029 IS - 2305-6320 (Print) IS - 2305-6320 (Electronic) IS - 2305-6320 (Linking) VI - 10 IP - 10 DP - 2023 Oct 4 TI - Monoclonal Gammopathy of Renal Significance with Deposits of Infrequent Morphology: Two Case Reports of Light and Heavy Chain Deposition Disease with Atypical Presentation and Literature Review. LID - 10.3390/medicines10100055 [doi] LID - 55 AB - BACKGROUND: Monoclonal immunoglobulin deposition disease (MIDD) includes three entities: light chain deposition disease (LCDD), heavy chain deposition disease (HCDD) and light and heavy chain deposition disease (LHCDD). The renal presentation can manifest with varying degrees of proteinuria and/or nephrotic syndrome, microhematuria, and often leads to end-stage renal disease. Given the rarity of LHCDD, therapeutic approaches for this condition remain inconclusive, as clinical trials are limited. CASE PRESENTATION: We report two male patients with underlying monoclonal gammopathy of renal significance (MGRS) associated with LHCDD lesions. Both cases had non-nephrotic proteinuria, moderately impaired renal function, and normal levels of C3 and C4. Light microscopy of the renal biopsies in both patients did not show lesions of nodular glomerulosclerosis. Immunofluorescence showed a staining pattern with interrupted linear IgA-kappa in patient #1 and IgA-lambda in patient #2 only along the glomerular basement membrane (GBM). Electron microscopy of patient #1 revealed electrodense deposits in the subendothelial and mesangial areas only along the GBM. DISCUSSION: In this case series, we discuss the clinical, analytical, and histopathological findings of two rare cases of LHCDD. Both patients exhibited IgA monoclonality and were diagnosed with monoclonal gammopathy of undetermined significance (MGUS) by the hematology department at the time of renal biopsy. Treatment with steroids and cytotoxic agents targeting the clone cells responsible for the deposition disease resulted in a favorable renal and hematologic response. FAU - De La Flor, Jose C AU - De La Flor JC AUID- ORCID: 0000-0001-9346-2279 AD - Department of Nephrology, Hospital Central de la Defensa, 28046 Madrid, Spain. FAU - Monroy-Condori, Maribel AU - Monroy-Condori M AD - Section of Nephrology and Hypertension, Hospital General Universitario Nuestra Senora del Prado, 45600 Talavera de la Reina, Spain. FAU - Apaza-Chavez, Jacqueline AU - Apaza-Chavez J AD - Department of Nephrology, Hospital Fuensanta, 28027 Madrid, Spain. FAU - Arenas-Moncaleano, Ivan AU - Arenas-Moncaleano I AD - Section of Nephrology and Hypertension, Hospital General Universitario Nuestra Senora del Prado, 45600 Talavera de la Reina, Spain. FAU - Diaz, Francisco AU - Diaz F AUID- ORCID: 0000-0001-5090-8488 AD - Department of Anatomic Pathology, Hospital Gregorio Maranon, 28007 Madrid, Spain. FAU - Guerra-Torres, Xavier E AU - Guerra-Torres XE AD - Section of Nephrology and Hypertension, Hospital General Universitario Nuestra Senora del Prado, 45600 Talavera de la Reina, Spain. FAU - Morales-Montoya, Jorge L AU - Morales-Montoya JL AD - Section of Nephrology and Hypertension, Hospital General Universitario Nuestra Senora del Prado, 45600 Talavera de la Reina, Spain. FAU - Lerma-Verdejo, Ana AU - Lerma-Verdejo A AD - Department of Hematology, Hospital General Nuestra Senora del Prado, 45600 Talavera de la Reina, Spain. FAU - Sandoval, Edna AU - Sandoval E AD - Department of Hematology, Hospital Central de la Defensa, 28046 Madrid, Spain. FAU - Villa, Daniel AU - Villa D AUID- ORCID: 0000-0001-8982-8442 AD - Department of Nephrology, Hospital Clinica Universiad Navarra, 31009 Pamplona, Spain. FAU - Vieru, Coca-Mihaela AU - Vieru CM AD - Department of Anatomic Pathology, Hospital Gregorio Maranon, 28007 Madrid, Spain. LA - eng PT - Case Reports DEP - 20231004 PL - Switzerland TA - Medicines (Basel) JT - Medicines (Basel, Switzerland) JID - 101671069 PMC - PMC10608252 OTO - NOTNLM OT - light and heavy chain deposition disease OT - monoclonal gammopathy of renal significance OT - monoclonal immunoglobulin deposits disease COIS- The authors declare no conflict of interest. EDAT- 2023/10/27 12:43 MHDA- 2023/10/27 12:44 PMCR- 2023/10/04 CRDT- 2023/10/27 06:56 PHST- 2023/07/21 00:00 [received] PHST- 2023/09/02 00:00 [revised] PHST- 2023/09/26 00:00 [accepted] PHST- 2023/10/27 12:44 [medline] PHST- 2023/10/27 12:43 [pubmed] PHST- 2023/10/27 06:56 [entrez] PHST- 2023/10/04 00:00 [pmc-release] AID - medicines10100055 [pii] AID - medicines-10-00055 [pii] AID - 10.3390/medicines10100055 [doi] PST - epublish SO - Medicines (Basel). 2023 Oct 4;10(10):55. doi: 10.3390/medicines10100055.